English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

specific for maternal cells correlated with SLE disease activity. Levels of maternal microchimerism were not increased in SLE patients with active disease, but rather tended to be lower (75.6 per million maternal cells in controls, SD 282, versus 3.3 in SLE, SD 11, P=0.06). Of controls tested, MMc was detected in 34%, compared to 23% of SLE patients (P=0.4). Of the seven SLE patients with MMc, three had a history of premature birth (<35 weeks) with low birth weight (LBW, range 1.96-2.27 Kg). Overall, SLE patients had an increased prevalence of prematurity (15.4%) and LBW (<2.5 Kg, 14.7%) compared to local controls (no prematurity or LBW was reported), patients with scleroderma (10.8% prematurity, 8.3% LBW), Raynaud Phenomenon without underlying systemic disease (6.3% prematurity, 6.3% LBW), or historic national frequencies (5-8%).

Chimeric maternal cells as T lymphocyte targets in pediatric SLE